| Description |
1 online resource (781 pages) |
| Series |
Pharmacy Education Ser |
|
Pharmacy Education Ser
|
| Contents |
Cover; Half Title; Title Page; Copyright Page; Table of Contents; Preface; Authors; Chapter 1: The cell; 1.1 Plasma membrane; 1.1.1 Structure and function of the plasma membrane; 1.1.2 Membrane transport; 1.2 Membrane potential; 1.2.1 Development of the resting membrane potential; 1.3 Electrical signals; 1.3.1 Graded potentials; 1.3.2 Action potentials; 1.3.3 Conduction of the action potential; 1.4 Synaptic transmission; 1.4.1 Chemical synapses; 1.4.2 Summation; 1.4.3 Interconnections between neurons; 1.4.4 Factors affecting synaptic transmission; 1.4.4.1 Altered release of a neurotransmitter |
|
1.4.4.2 Altered interaction of a neurotransmitter with its receptor1.4.4.3 Altered removal of a neurotransmitter from the synaptic cleft; 1.4.4.4 Replacement of a deficient neurotransmitter; 1.5 Cell injury; 1.5.1 Cellular adaptation; 1.5.2 Mechanisms of cell injury; 1.5.3 Manifestations of cellular injury; 1.5.4 Cell death; 1.5.5 Tissue repair; 1.5.6 Steps in tissue (wound) repair; Medical terminology; Bibliography; Chapter 2: Homeostasis; 2.1 Homeostasis; 2.1.1 Negative feedback; 2.1.2 Positive feedback; Medical terminology; Bibliography; Chapter 3: The immune system |
|
3.1 Overview of immune function3.1.1 Agents of infectious disease; 3.1.2 Effector cells of the immune system; 3.1.3 Immune responses; 3.1.4 Innate immune system; 3.1.5 Adaptive immune system; 3.1.5.1 Classification of antibodies; 3.1.5.2 Structure of antibodies; 3.1.5.3 Actions of antibodies; 3.1.5.4 Clonal selection theory; 3.1.5.5 Primary versus secondary responses; 3.1.5.6 Active versus passive immunity; 3.1.5.7 Types of T cells; 3.1.5.8 Actions of T cells; 3.1.5.9 MHC molecules; 3.2 Alterations in immune function; 3.2.1 Hypersensitivity reactions; 3.2.1.1 Type I hypersensitivity reaction |
|
3.2.1.2 Type II hypersensitivity reaction3.2.1.3 Type III hypersensitivity reaction; 3.2.1.4 Type IV hypersensitivity reaction; 3.2.2 Autoimmune disease; Medical terminology; Bibliography; Chapter 4: Inflammation; 4.1 Inflammatory mediators; 4.1.1 Histamine and mast cells; Chapter 5: Blood and hemostasis; 5.1 Blood; 5.1.1 Plasma; 5.1.2 Erythrocytes; 5.1.3 Leukocytes; 5.1.4 Platelets; 5.2 Hemostasis; 5.3 Alterations in hemostasis; 5.3.1 Conditions associated with decreased coagulation; 5.3.1.1 Hemophilia; 5.3.1.2 von Willebrand disease; 5.3.1.3 Vitamin K deficiency; 5.3.1.4 Liver disease |
|
5.3.2 Conditions affecting platelets5.3.2.1 Thrombocytopenia; 5.3.2.2 Immune thrombocytopenia purpura; 5.3.2.3 Antiphospholipid syndrome; 5.3.3 Conditions leading to increased blood coagulation (hypercoagulability); 5.3.4 Disseminated intravascular coagulation (DIC); 5.3.4.1 Manifestations of DIC; 5.3.4.2 Treatment of DIC; 5.4 Alterations in hematologic function and oxygen transport; 5.4.1 Hematopoiesis; 5.4.2 Anemia; 5.4.2.1 General manifestations of anemia; 5.4.3 Types of anemia; 5.4.3.1 Hemolytic anemia; 5.4.3.2 Blood loss anemia; 5.4.4 Inherited anemia; 5.4.4.1 Sickle cell disease |
| Notes |
5.4.4.2 Thalassemia |
|
Print version record |
| Subject |
Human physiology.
|
|
Physiology, Pathological.
|
|
Drugs.
|
|
Physiological Phenomena
|
|
Pharmaceutical Preparations
|
|
Pharmacy -- methods
|
|
Drugs
|
|
Human physiology
|
|
Physiology, Pathological
|
| Form |
Electronic book
|
| Author |
Zdanowicz, Martin M
|
| ISBN |
9780429522895 |
|
0429522894 |
|
9780429536366 |
|
0429536364 |
|
